INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) is one of six HIV/AIDS clinical trials networks funded in 2006 by the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health.

Since then, INSIGHT's scope has broadened. Our mission is to define optimal strategies for the management of HIV and other infectious diseases through a global clinical research network. INSIGHT conducts studies worldwide. 

INSIGHT is currently conducting the START study. Further analyses are ongoing on data from studies that were previously coordinated by the Terry Beirn Community Programs for Clinical Research on AIDS and the ESPRIT Group.

START (Strategic Timing of AntiRetroviral Treatment) is investigating the optimal time to begin antiretroviral therapy (ART) in over 200 sites around the globe.